Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


J. Nutr. First published March 25, 2009; doi:10.3945/jn.108.101451
Journal of Nutrition, doi:10.3945/jn.108.101451
Vol. 139, No. 5, 987-992, May 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplemental Material
Right arrow All Versions of this Article:
139/5/987    most recent
jn.108.101451v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sluijs, I.
Right arrow Articles by van der Schouw, Y. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sluijs, I.
Right arrow Articles by van der Schouw, Y. T.
© 2009 American Society for Nutrition


Nutritional Epidemiology

Dietary Carotenoid Intake Is Associated with Lower Prevalence of Metabolic Syndrome in Middle-Aged and Elderly Men1,2

Ivonne Sluijs*, Joline W. J. Beulens, Diederick E. Grobbee and Yvonne T. van der Schouw

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands

Carotenoids have antioxidant properties. Little is known about the relation of dietary carotenoid intake on metabolic syndrome risk. We examined whether dietary carotenoid intake was associated with metabolic syndrome and metabolic syndrome risk factors. We conducted a population-based, cross-sectional study in 374 men aged 40–80 y. Intakes of β-carotene, {alpha}-carotene, β-cryptoxanthin, lycopene, lutein, and zeaxanthin were estimated using a validated FFQ. Presence of metabolic syndrome was determined using fasting serum glucose, triglyceride, and HDL-cholesterol concentrations, waist circumference, and systolic and diastolic blood pressure. Metabolic syndrome was present in 22% of the men. After adjustment for confounders, total carotenoid and lycopene intakes were inversely associated with presence of metabolic syndrome [relative risk (RR) quartile 4 vs. quartile 1 (95% CI) 0.42 (0.20–0.87), P-trend 0.02; and 0.55 (0.28–1.11), P-trend 0.01, respectively]. For β-carotene, a decreased risk was observed for each quartile of intake compared with the first [RR quartile 4 vs. quartile 1 (95% CI) 0.58 (0.33–1.02)]. Higher total carotenoid, β-carotene, {alpha}-carotene, and lycopene intakes were associated with lower waist circumferences and visceral and subcutaneous fat mass. Higher lycopene intake was related to lower serum triglyceride concentrations. In conclusion, higher total carotenoid intakes, mainly those of β-carotene and lycopene, were associated with a lower prevalence of metabolic syndrome and with lower measures of adiposity and serum triglyceride concentrations in middle-aged and elderly men.


* To whom correspondence should be addressed. E-mail: i.sluijs-2{at}umcutrecht.nl.

Manuscript received 24 October 2008. Initial review completed 3 December 2008. Revision accepted 16 February 2009.

Published online 25 March 2009.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2009 by American Society for Nutrition